Herbalife

Herbalife has approved a three-year share buyback program of $250 million that includes open-market repurchases, privately negotiated transactions and accelerated share repurchase agreements. The board of directors views the move as an expression of confidence in the business strategy, the financial outlook and the company’s ability to generate sustainable free cash flow. The program is flexible, does not obligate the purchase of any specific number of shares, and can be adjusted or suspended depending on market conditions, price and liquidity. » More on de.investing.com

Herbalife reconfirms the guidance given on August 5 and continues to expect year-over-year net sales growth for both Q3 and full-year 2026 on a reported and currency-adjusted basis. For Q3 the company forecasts net sales growth of 0.5–4.5% (reported) and 1.5–5.5% (currency-adjusted), adjusted EBITDA of $160–180 million and capital expenditures of $15–25 million. For full-year 2026 it expects net sales growth of 2.5–5.5%, adjusted EBITDA of $670–690 million (reported) and $690–710 million (currency-adjusted), and CapEx of $50–70 million. CFO John DeSimone stresses the outlook is “fully on track” and the company expects continued year-over-year net sales growth. » More on de.investing.com

Herbalife announced that CEO Stephan Gratziani will resign effective October 31, 2026; CFO John DeSimone will become interim CEO from November 1, 2026 while a succession committee searches for a permanent replacement. Gratziani will remain as an advisor focused on strategy and business development and intends to return to his distributor network. The company reaffirmed its Q3 and full-year guidance, but leadership uncertainty, increased insider selling and a challenging macro environment sent the stock down about 12.7% intraday to $10.41. » More on de.investing.com